Last Edition: September 24-25 2020,
Digitally Streamed from Lausanne

Programme 2020

The Summit is organized around eight consecutive plenary panel sessions over two days.

13.30 - 14.00 CET
Official Opening
Brian Hashemi , Salus Partners SA
Nasri Nahas, Biopôle SA
Raphael Conz, Economic Promotion Manager at SPEI, Vaud
14.00 - 15.30 CET
Translational Medicine: Immuno-oncology
Lana Kandalaft, Department of oncology UNIL CHUV, Lausanne University Hospital, Ludwig Institute for Cancer Research Lausanne
Ana Cerdeira, Molecular Partners
Jing Watnick, Vigeo Therapeutics
Michele De Palma, EPFL
Freddy Radtke, EPFL
Christopher Nicodemus, AIT Strategies (Franconia, NH USA)
15.40 - 17.10 CET
Next Generation Diagnostics in Oncology: The Promise of the OMICS Age
Miro Venturi
Giulio Superti Furga, Medical University of Vienna
Massimo Bocchi, CellPly Srl
Christian Ruiz, University of Basel
Alexandra Vallon-Eberhard, Roche Diagnostics
17.20 - 18.50 CET
From Data to Decision: Applied Artificial Intelligence in Oncology
Robert Murphy, Carnegie Mellon University
Maryellen Giger, The University of Chicago
Ron Alfa, Recursion Pharmaceuticals
Anant Madabhushi, Case Western Reserve University
Sahar Hosseinian, Novigenix SA
14.00 - 15.30 CET
CAR-T Cell Therapy: Challenges and Opportunities
Georges Coukos, Department of oncology UNIL CHUV, Lausanne University Hospital, Ludwig Institute for Cancer Research Lausanne
Raphaël Stadelmann, Service d’hématologie, CHUV, Lausanne
Jens Hasskarl, Celgene a BMS Company
Caroline Arber-Barth, Department of oncology UNIL CHUV , Ludwig Institute for Cancer Research Lausanne, University of Lausanne and Lausanne University Hospital
Li Tang, EPFL
Dorothea Ledergerber, Novartis
16.00 - 17.30 CET
Health Economics & Access to Innovation: What Does It Mean for Patients post COVID-19?
Herb Riband, InnAxx Consulting
Christina Rångemark Åkerman, Dell Medical School at the University of Texas
Bettina Ryll, Melanoma Patient Network Europe
Titta Rosvall-Puplett, Bristol Myers Squibb (BMS)
Kolleen Kennedy, Varian Medical Systems
18.00 - 19.30 CET
Convergence for Better Health Outcomes: Connecting the Dots & Salus Award
William Burns, Molecular Partners
Lana Kandalaft, Department of oncology UNIL CHUV, Lausanne University Hospital, Ludwig Institute for Cancer Research Lausanne
Miro Venturi
Dorothea Ledergerber, Novartis
Robert Murphy, Carnegie Mellon University
Herb Riband, InnAxx Consulting
Brian Hashemi , Salus Partners SA
Antoine Papiernik, Sofinnova Partners

Listen to
their minds

Past Editions


2019
2018

Programme  2019

8:00 - 9:00
Wake up Coffee
9:00 - 10:15
Health & Economics
Prevention & Holistic Solutions to benefit Patients and Society
Herb Riband, InnAxx Consulting
Rebecca Morton Doherty, C/Can City Cancer Challenge
Manuela Eicher, CHUV - UNIL
Xavier Franz, VARIAN
Herve Lamarque, Incyte
Suzanne Wait, The Health Policy Partnership
10:45 - 12:00
Medical Devices in Oncology:
A New Generation of Therapeutic Companions
Diana Saraceni, Panakes
Antonino Amato, BetaGlue Technologies
Eugene Bajorinas, Novian Health
Ata Tuna Ciftlik, Lunaphore Technologies
Thomas Hefti, Novocure
Frederic Sottilini, CarThera
12:00 - 13:30
Networking Lunch
13:30 - 14:45
Emerging Nuclear Medicines:
A New Era for Targeted Therapy
Ebrahim Delpassand, RadioMedix
Julien Dodet, Orano Med
Andreas Kjaer , University of Copenhagen
Alexander McEwan, IPSEN
Thomas Travis , Advanced Accelerator Applications (AAA)
15:15 - 16:30
Regulatory Affairs:
Accelerating Regulatory Approval Novel Solutions
Ayse Baker, Chugai Pharma
Stella Augustus, Seattle Genetics
Laura Millichamp , InsideReg Sàrl
Vann Parker, Precision for Medicine
16:30 - 17:30
Farewell Apero
17:30
End of the Convergence in Oncology Summit 2019
11:00 - 12:45
Registration & Welcome Lunch
12:45 - 13:15
Summit Official Opening
Raphael Conz, Economic Promotion Manager at SPEI, Vaud
Brian Hashemi , Salus Partners SA
Nasri Nahas, Biopôle SA
13:15 - 14:30
Advances in Molecular Diagnostics:
Early Cancer Detection & Therapy Optimization
Jan Groen, Novigenix
Miro Venturi
Ralf Hoffmann, Philips Research
Gitte Pedersen, Genomic Expression
Manon Van Engeland, Maastricht University
Max Van Min, Cergentis
14:30 - 15:45
Artificial Intelligence in Oncology:
Mastering Signal to Noise
Stephan Morgenthaler, EPFL
Andrea Dunbar, CSEM
Christophe Patris de Broe Zeilas, Deep Cube
Wim Van Criekinge, Ghent University
Jack Kuipers , ETH Zurich
16:30 - 17:45
Convergence for Better Health Outcomes
William Burns, Molecular Partners
Pedro Romero, Ludwig Cancer Research
Ayse Baker, Chugai Pharma
Ebrahim Delpassand, RadioMedix
Herb Riband, InnAxx Consulting
Miro Venturi
18:00 - 18:30
Salus Excellence Award
Brian Hashemi , Salus Partners SA
Chris Martin, ADC Therapeutics
William Burns, Molecular Partners
19:00 - 21:30
Journey Dinner at Aquatis Aquarium
Close

Programme  2018

11:30 - 12:45
Welcome
Registration & Networking Lunch
12:45 - 13:30
Summit Official Opening
Take off: Challenges & Opportunities in Oncology
Raphael Conz, Economic Promotion Manager at SPEI, Vaud
Catherine Labouchère, Isrec Foundation
Brian Hashemi , Salus Partners SA
Nasri Nahas, Biopôle SA
13:30 - 14:45
Digitalization at the Service of Oncology:
from Prevention to Monitoring
Brian Hashemi , Salus Partners SA
Christina Busmalis, IBM Watson Health
Antoine De Weck, Novartis
Sorin Draghici, Wayne State University
Olivier Michielin, CHUV
Vaclav Potesil, OPTELLUM
Christopher Rudolf, Volv Global SA
Thierry Weber, Vivactis
15:30 - 16:45
Innovation in Prevention & Diagnostics
Cristina Stefan, Roche Diagnostics
Jurgi Camblong, Sophia genetics
Nicolas Demierre, Novigenix
Erik De Heus , SkinVision
Heinrich Röder, Biodesix
Hiroaki Tanaka, Debiopharm
17:15 - 18:30
Innovation in Therapeutics
Karen Zinkewich-Peotti, Ipsen
Venkat Reddy, Glenmark Pharmaceuticals
Chris Martin, ADC Therapeutics
Nicolas Mach, MaxiVAX
Lana Kandalaft, Department of oncology UNIL CHUV, Lausanne University Hospital, Ludwig Institute for Cancer Research Lausanne
Patrick Amstutz, Molecular Partners
18:30 - 19:30
Cocktail & Lessons Learned:
An Investor Perspective
Tania Dussey-Cavassini, Swiss Federal Office of Pubic Health
Brian Hashemi , Salus Partners SA
Vincent Ossipow, NeoMed
Diana Saraceni, Panakes
Marc Sluijs, DIGITALHEALTH.NETWORK
Cristina Stefan, Roche Diagnostics
Karen Zinkewich-Peotti, Ipsen
19:30 - 20:00
Salus Partners Excellence in HealthTech Award
20:00 - 21:45
Journey Dinner at Aquatis Aquarium
22:00
End of the Convergence in Oncology Summit 2018
Close

Keep me posted

Subscribe our contact list to receive updates about the Convergence in Oncology Summit.